Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
811.00    3.00 (0.37%)
Bid:
811.00
Ask:
812.00
Spread: 1.00 (0.123%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

8 May 2019 10:04

RNS Number : 3697Y
Savills PLC
08 May 2019
 

 

8 May 2019

SAVILLS PLC

("Savills" or "the Company")

AGM Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following AGM statement.

 

During the year to date the Group has traded in line with our expectations. Globally, our transaction businesses have continued to maintain strong market shares although, as anticipated, volumes in certain markets have been subdued as a result of political and economic uncertainty. Our Consultancy, Property Management and Investment Management businesses have continued to perform well.

 

In the UK, trading has been resilient despite increased political uncertainty. In our Residential Transaction business there has been a healthy increase in indicators which are normally a precursor to increased market activity. Of particular note is strong double digit increases in new buyers registered and a year-on-year increase in revenue in the prime Central London market. The Commercial Transaction business is also proving resilient, particularly in Central London, however, volumes across the UK have declined and development activity is relatively subdued.

 

In Asia Pacific, Savills has had a good start to the year, with Hong Kong, Mainland China, Singapore and Vietnam showing year-on-year revenue growth.

 

In North America, the business has successfully rebranded to Savills and continued its strong revenue performance from Q4 2018 through the period, with corporates generally active in relatively benign market conditions. The New York, Washington and Californian markets have proved particularly active to date.

 

In Continental Europe and the Middle East, we have traded in line with our expectations, with good year-on-year revenue growth in Ireland, France, the Netherlands and the Czech Republic. In Sweden, the new Capital markets and leadership team have started well accumulating a strong pipeline of potential transaction activity for the second half of the year.

 

Savills Investment Management has performed as expected. As previously announced, we successfully concluded the search for a new CEO for Savills Investment Management , with Alex Jeffrey due to join the firm later in the year.

 

Whilst the year has started as expected, the first few months typically represent a relatively modest proportion of the expected outturn for the full year. In the UK market, there remains significant investor demand but commercial transaction activity in the next few months may continue to be overshadowed by the prolonged uncertainty over Brexit, the exact impact of which is difficult to determine at present. We do, however, expect some strengthening of activity in certain overseas markets and, despite a greater weighting towards H2 than last year, we continue to anticipate overall performance for 2019 to be in line with our expectations.

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

David Allchurch

Elizabeth Snow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMLIFIAELITIIA
Date   Source Headline
14th Jan 20217:00 amRNSYear End Trading Update
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20208:59 amRNSNon-executive Director changes
14th Dec 20209:45 amRNSDirector/PDMR Shareholding
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
3rd Nov 20202:26 pmRNSHolding(s) in Company
22nd Oct 20205:41 pmRNSHolding(s) in Company
13th Oct 20205:22 pmRNSDirector/PDMR Shareholding
1st Oct 202010:00 amRNSTotal Voting Rights
14th Sep 202011:05 amRNSDirector/PDMR Shareholding
2nd Sep 202010:41 amRNSHolding(s) in Company
13th Aug 20205:00 pmRNSDirector/PDMR Shareholding
6th Aug 20207:00 amRNSHalf-year Report
4th Aug 20203:22 pmRNSTotal Voting Rights
21st Jul 202010:00 amRNSBlock listing Interim Review
13th Jul 20202:15 pmRNSHolding(s) in Company
13th Jul 202012:26 pmRNSDirector/PDMR Shareholding
6th Jul 202010:13 amRNSHolding(s) in Company
6th Jul 202010:09 amRNSHolding(s) in Company
1st Jul 20204:51 pmRNSDirector/PDMR Shareholding
1st Jul 202010:00 amRNSTotal Voting Rights
30th Jun 20204:52 pmRNSDirector/PDMR Shareholding
25th Jun 202011:27 amRNSResult of AGM
25th Jun 20207:00 amRNSAGM Statement
11th Jun 202011:29 amRNSDirector/PDMR Shareholding
5th Jun 20201:03 pmRNSDirectors Remuneration Policy - Clarification
5th Jun 202012:42 pmRNSDirectors Remuneration Policy - Clarification
1st Jun 20207:00 amRNSTotal Voting Rights
12th May 202012:01 pmRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSTotal Voting Rights
30th Apr 202012:15 pmRNSDisclosure of rights attached to equity shares
28th Apr 20203:53 pmRNSDirector/PDMR Shareholding
16th Apr 202011:56 amRNSDirector/PDMR Shareholding
6th Apr 202012:37 pmRNSAnnual Report and AGM Notice
1st Apr 20207:00 amRNS2020 AGM & 2019 final and supplemental dividends
1st Apr 20207:00 amRNSTotal Voting Rights
20th Mar 20205:33 pmRNSDirector/PDMR Shareholding
20th Mar 20201:40 pmRNSDirector/PDMR Shareholding
13th Mar 20201:43 pmRNSDirector/PDMR Shareholding
12th Mar 20207:00 amRNSAcquisition
12th Mar 20207:00 amRNSFinal Results
11th Mar 20201:12 pmRNSDirector/PDMR Shareholding
26th Feb 202012:58 pmRNSHolding(s) in Company
17th Feb 20203:29 pmRNSBlock listing Interim Review
11th Feb 20205:00 pmRNSDirector/PDMR Shareholding
3rd Feb 202011:00 amRNSTotal Voting Rights
21st Jan 20209:00 amRNSBlock listing Interim Review
13th Jan 202012:04 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSYear end Trading Update
7th Jan 202010:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.